Assessment of ARIA Sufficiency: Brineura (cerliponase alfa)

    Basic Details
    Approval Date
    Thursday, April 27, 2017
    Health Outcome(s)
    device related complications
    hypersensitivity reactions
    serious cardiovascular adverse events